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Gap junctional intercellular communication (GJIC) plays a critical role in tissue
development and differentiation and probably in carcinogenesis. The purpose
of the study was to evaluate the expression and localisation of Cx43 in 40 cases
of mammary dysplasia and 29 cases of breast cancer (without primary chemo-
therapy). The tissue sections were investigated for Cx43 expression by immuno-
histochemistry. In the normal mammary gland there was an intercellular, punc-
tate staining pattern, mainly between myoepithelial cells, characteristic of func-
tional gap junctions. In dysplasias there was mainly mixed (cytoplasmic and
intercellular) staining and in most cases of breast cancer we observed diffuse or
granular, but cytoplasmic, staining of Cx43. Our results demonstrated that ex-
pression of Cx43 in dysplasias and breast cancer is changed and GJIC is probably
impaired because of disruption of functional gap junction formation especially
between breast cancer cells.
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INTRODUCTION
Gap junctions are specialised cell membrane
channels connecting adjacent cells that facilitate the
transfer of small (Mr < 1000) molecules between
cells. The mammary epithelium contains Cx43 be-
tween myoepithelial cells [4]. Loss of communica-
tion via gap junctions appears to play a role in onco-
genesis [3, 4] and up-regulation of Cxs has been
shown to restore normal phenotypes and retard tu-
mour cell growth [3]. In several studies lack of con-
nexin expression and/or function of gap junction
channels was demonstrated in human tumours.
However, in the breast the situation is still unclear.
Different scientists have observed increased [1] as
well as decreased [3] expression of connexins in
breast cancer cells. There have been very few stud-
ies concerning the existence of connexins in pre-neo-
plastic cells and lack of evidence to evaluate the ex-
pression of Cxs in mammary dysplasia. The aim of
this study was to evaluate the expression of Cx43 in
breast cancer (intraductal carcinoma and invasive
carcinoma of the breast) compared with the normal
mammary gland and with mammary dysplasia with
variable pathologial findings such as cysts, with or
without apocrine metaplasia, typical or atypical duc-
tal hyperplasia, adenosis and papillomas.
MATERIAL AND METHODS
Formalin-fixed and paraffin-embedded tissue
samples were investigated as follows: 25 cases of
normal human breast; 40 benign mammary dyspla-
sias including adenosis (30 cases), cysts (30 cases),
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Figures 1. Immunohistochemical detection of Cx43 expression in the human breast. A, B. Granular, intercellular expression
of Cx43 between myoepithelial cells in the normal breast duct and in the small cyst. Magn. 200 ×, 400 ×; C. Mixed (intercellular and
cytoplasmic) staining pattern in the adenosis. Magn. 200 ×; D. Weak cytoplasmic staining in the atypical intraductal hyperplasia. Magn.
400 ¥; E. Heterogenous cytoplasmic staining pattern in the intraductal carcinoma. Magn. 400 ×; F. Strong cytoplasmic staining in
breast cancer cells. Magn. 200 ×.
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intraductal hyperplasia (20 cases), intraductal atyp-
ical hyperplasia (10 cases), papilloma (15 cases), as
well as 11 intraductal carcinomas and 29 cases of
ductal carcinoma (18 cases in grade G2 and 11 cas-
es in grade G3). Immunostaining was performed
using goat polyclonal anti-Cx43 antibody (Santa Cruz
Biotechnology, USA) in a dilution rate of 1:200.
A streptavidin-biotin-peroxidase complex technique
was used to reveal antibody-antigen reactions (LSAB
+ Kit, Dako, Denmark) according to the protocol
provided by the manufacturer. Staining was routinely
developed using 3,3’-diaminobenzidine as a chro-
mogen (Dako, Denmark). Negative controls were
carried out with omission of the primary antibody.
Sections were counterstained with haematoxylin. The
results of immunostaining were evaluated by light
microscopy using a 200× magnification by two in-
dependent pathologists.
RESULTS AND DISCUSSION
The anti-Cx43 antibody gave punctate intercel-
lular immunostaining mainly for the myoepithelial
cells of the normal human breast (Fig. 1A). In the
lesions of papilloma, adenosis and intraductal hy-
perplasia (Fig. 1C) was observed mixed, intercellular
and cytoplasmic immunoreactivity (28/30), and in
some cases membrane-associated staining for myo-
epithelial cells was also seen. The majority of cysts
were lined with apocrine epithelium, in this case cy-
toplasmic, but it seemed that no specific immunore-
activity was shown. In the case of cysts without apo-
crine metaplasia we observed a very weak, intercel-
lular staining pattern (Fig. 1B), but only in a few cells.
In the atypical ductal hyperplasia heterogenous (inter-
cellular and cytoplasmic) staining was seen (Fig. 1D),
but this was sparse compared to the typical intra-
ductal hyperplasia. In the majority of cases (7/11) of
intraductal carcinoma no immunoreactivity was seen
in the cancer cells. In one case, the carcinoma cells
had intercellular, granular staining for Cx43 while in
other cases (3/11) there was a weak, cytoplasmic stain-
ing pattern (Fig. 1E). The majority (26/29) of invasive
carcinomas exhibited cytoplasmic, mainly diffuse im-
munostaining in carcinoma cells (Fig. 1F) and there
was a predominantly strong reaction (15/26). In two
cases we observed punctate staining aggregations be-
tween cancer cells. In only three cases of the com-
pletely evaluated samples was no reaction found. Fur-
thermore, in the breast arterioles the endothelial and
smooth muscle cells stained positively for Cx43.
It has been shown that in normal human breast
epithelium Cx26 and Cx43 are present [4]. Our find-
ing of punctate aggregations of Cx43 between my-
oepithelial cells is in agreement with the results of
a recent study made by Jamieson et al. [1]. Further-
more, the present study demonstrated for the first
time that in various pathological components of
benign mammary dysplasia expression of Cx43 is
changed, ranging from the characteristic intercellu-
lar pattern present in cysts, the mixed (intercellular
and cytoplasmic) pattern in the case of papilloma,
adenosis and intraductal hyperplasia, and finally
down-regulation of Cx43 expression in the atypical
ductal hyperplasia. In the letter case, our observa-
tions are compatible with those of King et al. [2], in
which a loss of Cx43 expression is described in pre-
malignant lesions of the cervix (cervical dysplasia).
Parallel to our results, Jamieson et al. [1] and Laird
et al. [3] failed to identify Cx43 in the intraductal
carcinoma cells. It is, therefore, probable that loss
of Cx43 expression may be an early event in the car-
cinogenic process.
In several studies the absence of connexin expres-
sion and/or function of gap junction channels has
been demonstrated in human tumours [3, 5]. It has
been suggested that genes-encoding connexins
could play a tumour suppressor role. On the other
hand, Jamieson et al. [1] investigated the immuno-
histochemical expression of Cx26 and Cx43 in breast
cancer cells and found mainly cytoplasmic heterog-
enous Cx26 and Cx43 immunostaining in breast can-
cer cells. Our findings are consistent with the results
of Jamieson et al. [1]. This could suggest that persis-
tent expression of Cx43 might be inconsistent with
a tumour suppressor role of Cxs, but it is possible
that breast cancer cells express Cx43 in cytoplasm,
which fails to traffic and assemble Cx43 into func-
tional gap junction channels at the cell surface. Fur-
ther investigation of Cxs expression, regulation and
gap junction traffic may shed light on the relation-
ship between gap junctions and mammary carcino-
genesis.
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